BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6470257)

  • 1. Impact of thoracic computed tomography on radiation therapy planning in Hodgkin disease.
    Meyer JE; Linggood RM; Lindfors KK; McLoud TC; Stomper PC
    J Comput Assist Tomogr; 1984 Oct; 8(5):892-4. PubMed ID: 6470257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thoracic CT scanning for mediastinal Hodgkin's disease: results and therapeutic implications.
    Rostock RA; Siegelman SS; Lenhard RE; Wharam MD; Order SE
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1451-7. PubMed ID: 6629888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma. Is the definition on the basis of a chest radiograph in the era of CT obsolete?
    Kriz J; Mueller RP; Mueller H; Kuhnert G; Engert A; Kobe C; Haverkamp U; Eich HT
    Strahlenther Onkol; 2012 Nov; 188(11):1020-4. PubMed ID: 23053141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT scan modification in the treatment of mediastinal Hodgkin's disease.
    Rostock RA; Giangreco A; Wharam MD; Lenhard R; Siegelman SS; Order SE
    Cancer; 1982 Jun; 49(11):2267-75. PubMed ID: 7074542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the respiratory cycle on mediastinal and lung dimensions in Hodgkin's disease. Implications for radiotherapy gated to respiration.
    Willett CG; Linggood RM; Stracher MA; Goitein M; Doppke K; Kushner DC; Morris T; Pardy J; Carroll R
    Cancer; 1987 Sep; 60(6):1232-7. PubMed ID: 3621109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hodgkin's patients with large mediastinal masses.
    Kumar PP; Good RR; Scheinos N
    Radiat Med; 1987; 5(4):112-20. PubMed ID: 3423298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral superomedial hilar displacement: a unique sign of previous mediastinal radiation.
    Harnsberger HR; Armstrong JD
    Radiology; 1983 Apr; 147(1):35-6. PubMed ID: 6828757
    [No Abstract]   [Full Text] [Related]  

  • 8. A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).
    Eich HT; Gossmann A; Engert A; Kriz J; Bredenfeld H; Hansemann K; Skripnitchenko R; Brillant C; Pfistner B; Staar S; Diehl V; Müller RP;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1187-92. PubMed ID: 17703895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
    Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal fibrosis simulating residual Hodgkin's disease.
    Markman M
    Am J Med Sci; 1984; 287(1):40-2. PubMed ID: 6702882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
    Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
    Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of radiation therapy in Hodgkin disease: experience and controversy. The 54th annual Janeway Lecture: 1989.
    Levitt SH; Lee CK; Aeppli D; Lindgren B; Peterson BA
    Cancer; 1992 Aug; 70(3):693-703. PubMed ID: 1623486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
    Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unusually long recurrence-free time following x-ray therapy of mediastinal tumors].
    Ratkóczy N
    Strahlentherapie; 1970 Sep; 140(3):273-4. PubMed ID: 5509809
    [No Abstract]   [Full Text] [Related]  

  • 16. Regression of Hodgkin disease in the mediastinum: a mathematical model.
    Fayos JV; Chen WC; Kim YH; Votaw ML
    Radiology; 1979 Dec; 133(3 Pt 1):731-5. PubMed ID: 504655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
    Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
    Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral lung hyperlucency after mediastinal irradiation.
    Wencel ML; Sitrin RG
    Am Rev Respir Dis; 1988 Apr; 137(4):955-7. PubMed ID: 3355004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?
    Ghalibafian M; Beaudre A; Girinsky T
    Radiother Oncol; 2008 Apr; 87(1):82-8. PubMed ID: 18037182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.